Table 5 Summary of ADCmean and ADCmin values per histopathological group
From: Role of diffusion weighted MR-imaging in the evaluation of malignant mediastinal lesions
Pathological entity | Number of cases and percentage (%) | ADCmean range average ± SD* | ADCmin range average ± SD* |
|---|---|---|---|
Lymphoma | 9 (27.3%) | (0.507–1.08) 0.733 ± 0.191 | (0.343–0.846) 0.541 ± 0.164 |
Central bronchogenic carcinoma | 10 (30.3%) | (0.501–1.633) 0.904 ± 0.342 | (0.354–1.474) 0.747 ± 0.336 |
Metastatic lymph nodes | 4 (12.1%) | (0.667–1.391) 1.033 ± 0.3 | (0.467–1.212) 0.822 ± 0.307 |
Thymic tumors | 4 (12.1%) | (0.847–1.233) 0.959 ± 0.184 | (0.708–1.111) 0.827 ± 0.191 |
Germ cell tumors | 4 (12.1%) | (0.568–2.44) 1.058 ± 0.921 | (0.431–1.701) 0.776 ± 0.616 |
Neurogenic tumors | 1 (3.03%) | 0.473 | 0.327 |
Angiosarcoma | 1 (3.03%) | Could not be measured** | |
Total | 33 (100%) | 0.884 ± 0.396 | 0.699 ± 0.326 |